Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 153
Filter
1.
BMC Vet Res ; 18(1): 62, 2022 Feb 01.
Article in English | MEDLINE | ID: mdl-35105366

ABSTRACT

BACKGROUND: Neoplasm in South American camelids (SAC) are commonly described. The most frequently reported type of neoplasm are lymphomas and difference in the age suffering from lymphomas of and llamas is seen. This report describes a case of a solitary lymphoma in a 5 years and 9 month old llama mare displaying the approach of diagnostic imaging and successful surgical treatment. CASE PRESENTATION: The llama was referred to the clinic for dyspnoea and inspiratory abnormal respiratory sounds. The clinical examination comprised blood cell count, ultrasonographic and radiographic examinations, endoscopy and fine needle aspiration cytology of a mass detected in the mid cervical region. The mass was surgically removed. Histopathological examination of the surgically removed mass diagnosed a malignant T-cell- lymphoma. According to the results of the clinical, ultrasonographic and radiographic examinations no tumor invasion was apparent in distant organs and the llama was discharged from the clinic seven days after surgery. CONCLUSION: Lymphoma has been reported to be the most common neoplasia in camelids and are more often described in young alpacas and in adult llamas. To the author´s knowledge the case presented here is the first that described a broad panel of diagnostic tools including ultrasound, radiographs, endoscopy, fine needle aspiration cytology and histopathoogical examination as well as a successful surgical treatment of a solitary lymphoma in camelids.


Subject(s)
Camelids, New World , Horse Diseases , Lymphoma, T-Cell , Lymphoma , Animals , Female , Horses , Lymphoma/pathology , Lymphoma/veterinary , Lymphoma, T-Cell/diagnostic imaging , Lymphoma, T-Cell/surgery , Lymphoma, T-Cell/veterinary , Radiography , T-Lymphocytes/pathology
2.
Gan To Kagaku Ryoho ; 49(13): 1473-1475, 2022 Dec.
Article in Japanese | MEDLINE | ID: mdl-36733106

ABSTRACT

Monomorphic epitheliotropic intestinal T-cell lymphoma(MEITL)is classified under type Ⅱ enteropathy-associated T-cell lymphoma(EATL). It is a rare disease with a low incidence rate. This study reports a case of a patient with MEITL who developed small intestinal perforation during chemotherapy. The patient was a 55-year-old woman who presented to a previous clinic with epigastric pain. Enteroscopy results showed a map-like ulcer in the jejunum. Examination of the tissue specimen collected from this site suggested T-cell lymphoma. The patient was referred to our hospital for chemotherapy. Seven days following the initiation of chemotherapy, an abdominal computed tomography(CT)revealed free air, leading to a diagnosis of gastrointestinal perforation. Emergency surgery was performed. Intraoperatively, bowel perforation and a degenerative ulcer were observed at 95 cm and 80 to 115 cm from the Treitz' ligament, respectively. In addition, all-layer intestinal necrosis was noted 150 and 90 cm from the terminal ileum. Total resection and anastomosis were performed. Postoperatively, the patient developed sepsis due to chemotherapy-related pancytopenia but recovered. She was discharged on postoperative day 24. Subsequently, positron emission tomography(PET)-CT revealed residual intestinal tumor cells and peritoneal dissemination. Chemotherapy was initiated, but there was no response. The patient died after 6.5 months. A radical treatment for MEITL has not yet been established. More case reports are needed to improve the prognosis of this disease.


Subject(s)
Enteropathy-Associated T-Cell Lymphoma , Intestinal Neoplasms , Intestinal Perforation , Lymphoma, T-Cell , Female , Humans , Middle Aged , Enteropathy-Associated T-Cell Lymphoma/complications , Enteropathy-Associated T-Cell Lymphoma/diagnosis , Enteropathy-Associated T-Cell Lymphoma/pathology , Intestinal Perforation/chemically induced , Intestinal Perforation/surgery , Ulcer/chemically induced , Ulcer/surgery , Lymphoma, T-Cell/drug therapy , Lymphoma, T-Cell/surgery , Lymphoma, T-Cell/complications , Intestinal Neoplasms/drug therapy , Intestinal Neoplasms/surgery , Intestinal Neoplasms/complications
4.
Open Vet J ; 10(3): 272-275, 2020 10.
Article in English | MEDLINE | ID: mdl-33282698

ABSTRACT

Background: Splenic lymphoma is commonly reported in domestic ferrets (Mustela putorious furo), but very rarely reported in wild Mustelidae species, including otters. One report described B-cell splenic lymphoma in an Asian small-clawed otter (Aonyx cinerea) that metastasized and was the primary reasoning for humane euthanasia (Stedman and Mills, 2014). Case Description: The current report describes a case of splenic T-cell lymphoma in a captive North American river otter (Lontra canadensis). The otter died several weeks after splenectomy and no evidence of metastasis was found on gross necropsy or histopathological evaluation. Conclusion: The splenectomy performed on this individual was presumptively curative for its splenic lymphoma. Extensive myocardial fibrosis was found, and suspected to have caused severe cardiac arrhythmia leading to acute death.


Subject(s)
Lymphoma, T-Cell/veterinary , Otters , Splenectomy/veterinary , Splenic Neoplasms/veterinary , Animals , Female , Lymphoma, T-Cell/surgery , Splenic Neoplasms/surgery , Treatment Outcome
5.
HNO ; 68(9): 695-697, 2020 Sep.
Article in German | MEDLINE | ID: mdl-32728760

ABSTRACT

A rare finding of primary cutaneous CD4+ small to medium-sized T­cell lymphoma (SMPTCL) in a fifteen-year-old patient is reported. This is a rare tumor entity for which there is currently no standardized treatment recommendation. At the interdisciplinary tumor board, the decision was made to resect the tumor and reconstruct the defect with a nasolabial advancement flap in a two-stage process. Follow-up examinations, currently over 3 years, have shown the patient to be free of recurrences.


Subject(s)
Lymphoma, T-Cell, Cutaneous , Lymphoma, T-Cell , Skin Neoplasms , Adolescent , CD4-Positive T-Lymphocytes , Humans , Lymphoma, T-Cell/diagnosis , Lymphoma, T-Cell/surgery , Lymphoma, T-Cell, Cutaneous/diagnosis , Lymphoma, T-Cell, Cutaneous/surgery , Neoplasm Recurrence, Local , Skin Neoplasms/diagnosis , Skin Neoplasms/surgery
6.
Pediatr Blood Cancer ; 67(8): e28480, 2020 08.
Article in English | MEDLINE | ID: mdl-32542941
7.
Am J Case Rep ; 21: e919032, 2020 Jan 20.
Article in English | MEDLINE | ID: mdl-31956261

ABSTRACT

BACKGROUND Primary effusion lymphoma (PEL) is a rare and aggressive non-Hodgkin lymphoma (NHL) that is responsible for 1% of all lymphomas not related to human immunodeficiency virus (HIV). PEL is characterized by human herpesvirus-8 (HHV-8) positivity in the absence of overt tumor burden that does not exhibit typical B cell or T cell immunophenotype characteristics. The exact mechanism of development is unknown, but it is hypothesized to develop from post-germinal B cell origin. Although it is most common in HIV patients, other immunocompromising comorbidities can be seen in conjunction with PEL, including liver cirrhosis. CASE REPORT We present the case of a 73-year-old HIV-seronegative man with alcohol-induced liver cirrhosis who was found to have T cell PEL of the pleural space diagnosed by thoracentesis. CONCLUSIONS Little is known regarding oncogenesis of T cell PEL, and few studies exist regarding appropriate treatment regimens for PEL as a whole, prompting need for further investigation and discussion to improve survival rates. Even in the absence of active HIV infection, PEL should be considered as a potential cause of pleural effusion in cirrhotic patients in order to prompt earlier treatment for the best chance of survival.


Subject(s)
HIV Seronegativity , Immunocompromised Host , Liver Cirrhosis/immunology , Lymphoma, Primary Effusion/surgery , Lymphoma, T-Cell/surgery , Thoracentesis , Aged , Humans , Male
8.
Clin Nucl Med ; 45(2): e88-e91, 2020 Feb.
Article in English | MEDLINE | ID: mdl-31652159

ABSTRACT

F-FDG PET/CT for a 74-year-old man with elevated serum soluble interleukin 2 receptor showed multiple intense uptake in the liver, spleen, and bone. A surgical biopsy from 2 of liver tumors confirmed hepatosplenic αß T-cell lymphoma. One and a half months after biopsy, FDG PET scan was performed again for staging before starting chemotherapy, and it showed the complete disappearance of all of the lesions. The excisional biopsy could be a possible trigger of his spontaneous regression.


Subject(s)
Liver Neoplasms/pathology , Liver Neoplasms/surgery , Lymphoma, T-Cell/pathology , Lymphoma, T-Cell/surgery , Neoplasm Regression, Spontaneous , Spleen/pathology , Aged , Biopsy , Fluorodeoxyglucose F18 , Humans , Liver Neoplasms/diagnostic imaging , Lymphoma, T-Cell/diagnostic imaging , Male , Positron Emission Tomography Computed Tomography
9.
Rev Esp Anestesiol Reanim (Engl Ed) ; 67(1): 39-43, 2020 Jan.
Article in English, Spanish | MEDLINE | ID: mdl-31776014

ABSTRACT

Complications induced by general anesthesia (GA) and neuromuscular relaxation (NMR) in anterior mediastinal mass (AMM) resection can be serious, especially when there are signs of compression of the airway or large vessels (dyspnea, orthopnea, etc.) (1). It is preferable to perform the procedure in spontaneous ventilation to avoid respiratory or cardiovascular collapse due to the supine position or to loss of negative intrathoracic pressure with GA and NMR. If the supine position and NMR are unavoidable, procedures should be performed in a step-wise manner, and rescue strategies should be prepared (rescue position, bronchoscope, sternotomy). Correct preoperative evaluation, adequate planning, and a multidisciplinary approach will ensure patient safety. We present the case of a child with a history of severe orthopnea and a diagnosis of AMM and lymphoblastic lymphoma (respiratory arrest and cardiovascular collapse during sedation for lumbar puncture and bone marrow biopsy) that did not respond to medical treatment and required resection surgery under GA with NMR.


Subject(s)
Anesthesia/methods , Lymphoma, T-Cell/surgery , Mediastinal Neoplasms/surgery , Patient Positioning/methods , Biopsy/methods , Child , Humans , Lymphoma, T-Cell/diagnostic imaging , Male , Mediastinal Neoplasms/diagnostic imaging , Sitting Position , Tomography, X-Ray Computed
11.
World Neurosurg ; 125: 339-342, 2019 05.
Article in English | MEDLINE | ID: mdl-30797915

ABSTRACT

BACKGROUND: We describe a patient affected by a T-cell primary central nervous system lymphoma (PCNSL) with highly aberrant specific B-cell markers (CD79a and CD20). An unusual imaging presentation leads us to misdiagnose this lesion for a meningioma and perform surgical resection. CASE DESCRIPTION: We think that this infrequent anatomic presentation might be due to the aberrant specific B-cell markers (CD79a and CD20) genotype expression. We believe this case to be relevant in order to appreciate the diagnosis of cerebral lymphomas according to various presentations. We wonder whether it was not the aberrant genotype that contributed to this quirky presentation and ultimately if surgery in PCNSL should not be discussed? CONCLUSIONS: Furthermore, this case calls attention to the complexity of lineage assignment, imaging diagnosis, and treatment strategy in PCNSL.


Subject(s)
Central Nervous System Neoplasms/diagnosis , Lymphoma, T-Cell/diagnosis , Meningioma/diagnosis , Aged , Antigens, CD20/metabolism , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Biomarkers, Tumor/metabolism , CD79 Antigens/metabolism , Central Nervous System Neoplasms/drug therapy , Central Nervous System Neoplasms/surgery , Diagnosis, Differential , Diagnostic Errors , Female , Humans , Lymphoma, T-Cell/drug therapy , Lymphoma, T-Cell/surgery , Magnetic Resonance Imaging , Meningeal Neoplasms/diagnosis , Meningeal Neoplasms/surgery , Meningioma/surgery , Multimodal Imaging , Positron-Emission Tomography , Tomography, X-Ray Computed
12.
World Neurosurg ; 118: 139-142, 2018 Oct.
Article in English | MEDLINE | ID: mdl-30030187

ABSTRACT

BACKGROUND: Brain involvement of hepatosplenic T cell lymphoma (HSTL) has not been reported so far. CASE DESCRIPTION: We observed an extremely rare case of HSTL, which is a rare and aggressive variant of peripheral T cell lymphoma, generally showing predominant infiltration to the liver, spleen, and bone marrow and involving the brain. A 41-year-old Japanese woman presented with dysarthria and numbness of the right hand. Radiologic examination revealed a single 3-cm mass in the left frontal cortex, which was totally removed. Pathologic examination of the specimen demonstrated T cell lymphoma with a γδ cytotoxic T cell phenotype. Multiplex polymerase chain reaction analyses confirmed monoclonality of T cell receptor γ. Systemic examination revealed infiltration of atypical T lymphoid cells of the same phenotype in bone marrow and the presence of hepatosplenomegaly. We diagnosed HSTL involving the brain. The patient was treated with several courses of intensive chemotherapy, but it failed to achieve remission. She died of sepsis 4 months after the surgery. CONCLUSIONS: HSTL can involve the brain. A diagnosis of HSTL involving the brain needs careful systemic evaluation. Timely and precise diagnosis that considers the systemic condition is important for appropriate treatment and better outcome.


Subject(s)
Brain/pathology , Liver Neoplasms/pathology , Lymphocytes/pathology , Lymphoma, T-Cell/pathology , Adult , Fatal Outcome , Female , Humans , Liver Neoplasms/diagnosis , Liver Neoplasms/surgery , Lymphoma, T-Cell/diagnosis , Lymphoma, T-Cell/surgery , Receptors, Antigen, T-Cell, gamma-delta/metabolism
13.
J Avian Med Surg ; 32(2): 128-132, 2018 06.
Article in English | MEDLINE | ID: mdl-29905106

ABSTRACT

An adult, wild-caught, female Florida scrub jay ( Aphelocoma coerulescens) was evaluated because of an observable mass on the ventral neck. Initial physical examination and diagnostic tests were performed, which revealed a subcutaneous mass. Surgical removal of the mass was attempted, but the bird died during surgery. Results of necropsy and histopathologic evaluation identified the mass as thymic lymphoma with proventricular metastasis. Immunohistochemical staining revealed strong cytoplasmic immunoreactivity for CD3 in the thymic mass and within the predominant lymphoid population in the serosal proventricular masses, which confirmed metastasis of T-cell lymphoma. To our knowledge, this is the first report of T-cell thymic lymphoma in a wild Florida scrub jay.


Subject(s)
Bird Diseases/pathology , Lymphoma, T-Cell/veterinary , Passeriformes , Proventriculus/pathology , Thymus Neoplasms/veterinary , Animals , Autopsy/veterinary , Biopsy, Fine-Needle/veterinary , Bird Diseases/surgery , Fatal Outcome , Female , Immunohistochemistry/veterinary , Lymphoma, T-Cell/pathology , Lymphoma, T-Cell/surgery , Neoplasm Metastasis , Thymus Neoplasms/pathology , Thymus Neoplasms/surgery
14.
Medicine (Baltimore) ; 97(12): e0181, 2018 Mar.
Article in English | MEDLINE | ID: mdl-29561433

ABSTRACT

RATIONALE: Primary testicular natural killer (NK)/T-cell lymphoma is an extremely rare and highly aggressive lymphoid malignancy. At present, only 20 cases have been reported. PATIENT CONCERNS: A 32-year-old Chinese man complained of discomfort and swelling of his right testicle for 3 months. Physical examination revealed a 10 × 10 × 9.5 cm mass on the right side of the scrotum area. DIAGNOSES: Pathologic evaluation showed effacement of normal testicular parenchymal architecture by small-to-medium-sized lymphoid cells with irregular nuclear profiles, and immunohistochemical studies positively expressed CD2, CD56, cytoplasmic CD3, granzyme B, perforin, and TIA-1. Therefore, the patient was diagnosed with primary testicular NK/T-cell lymphoma. INTERVENTIONS: The patient underwent CHOP (cyclophosphamide (CTX), pirarubicin (THP-ADM), vincristine (VCR), and prednisolone (PDN)) chemotherapy. OUTCOMES: The patient relapsed 5 months after his initial presentation and died after an infection and gastrointestinal bleed. LESSONS: Clinicopathological assessment of this rare case highlights the clinical and pathological features required to diagnose testicular NK/T-cell lymphoma. In addition, it highlights the dismal survival of these patients. We hope it may serve as a reference aiding prompt clinical diagnosis, which can hopefully improve the survival and quality of life of these patients.


Subject(s)
Lymphoma, T-Cell/diagnostic imaging , Lymphoma, T-Cell/pathology , Testicular Neoplasms/diagnostic imaging , Testicular Neoplasms/pathology , Adult , Antineoplastic Combined Chemotherapy Protocols , Diagnosis, Differential , Fatal Outcome , Humans , Lymphoma, T-Cell/drug therapy , Lymphoma, T-Cell/surgery , Male , Testicular Neoplasms/drug therapy , Testicular Neoplasms/surgery
15.
Bone Marrow Transplant ; 53(8): 993-1000, 2018 08.
Article in English | MEDLINE | ID: mdl-29434288

ABSTRACT

T-cell lymphomas are generally aggressive malignancies with poor prognosis. There are no standard treatment guidelines for T-cell lymphomas, and the timing of stem cell transplantation (SCT) is not well known. In this study, we investigated the outcomes of Taiwanese patients with T-cell lymphomas after SCT. We retrospectively analyzed 131 patients with T-cell lymphomas receiving SCT (autologous: 90, allogeneic: 41) from 2009 to 2014. More autologous SCT recipients were ALCL or in complete remission, and more allogeneic recipients had advanced disease. 56 patients who were sensitive to chemotherapy underwent SCT as upfront setting. The 2-year PFS and OS rates were 67.0 and 64.5%, respectively. Regarding disease status before transplantation, patients with CR1 had the best outcomes. Among different subtypes, patients with natural killer/T-cell lymphomas showed the worst outcomes, with 2-year OS rate of 23.5%. The OS rates for the other three major subtypes were as follows: 72.9% for ALCL; 75.0% for AITL; and 51.4% for PTCL-NOS. For more rare subtypes, such as ATLL and SPTCL, data from our study show that SCT can be beneficial. We concluded that upfront autologous SCT is feasible and effective for patients with low PIT, and disease status at transplant is the strong predictor of outcome.


Subject(s)
Lymphoma, T-Cell/surgery , Stem Cell Transplantation/methods , Transplantation, Homologous/methods , Adult , Female , Humans , Lymphoma, T-Cell/pathology , Male , Middle Aged , Retrospective Studies , Taiwan , Young Adult
17.
Eur J Surg Oncol ; 43(10): 1886-1893, 2017 Oct.
Article in English | MEDLINE | ID: mdl-28751057

ABSTRACT

INTRODUCTION: Information on primary small intestinal lymphoma is more limited than for gastric lymphoma because most of the previous studies did not focus on the former. Few prognostic indicators in primary intestinal lymphoma have been reliably established because of limited patient numbers and variations in criteria for patient selection. In this study, we retrospectively reviewed the clinical and pathological characteristics of small intestinal lymphoma cases from our hospital, to determine prognostic factors and to clarify the effect of surgical resection on prognosis. METHODS: Eighty-two patients were enrolled in this retrospective study between January 1997 and December 2012. Patients were divided into two groups based on whether or not they underwent surgical management. Gross resection was defined as complete removal of the primary lesion(s), as confirmed by the naked eye. Combined therapy refers to concurrent surgery and chemotherapy. The clinicopathological characteristics and long-term outcomes of patients were analyzed and compared between the two groups. RESULTS: Most of the patients had abdominal pain (75.6%), and some had loss of body weight (29.3%) and bowel perforation (22.0%). Sixty-two patients (75.6%) underwent surgical management. Patients in the surgery group presented with fewer B symptoms (fever, night sweats, and weight loss; P = 0.035) but more bulky disease (P = 0.009). The ileocecal region was the most common site of solitary involvement (34.1%). The most common reason for surgery was for tumor-related complications (61.3%). Seven patients (11.3%) developed major complications of surgery, but these were not related to the indication, timing, or type of surgery. Only major surgical complications were statistically significant in relation to early mortality (P = 0.004). The estimated 5-year progression-free survival (PFS) was 35.1% and 5-year overall survival (OS) was 43.2%. Univariate analysis revealed that patients in the surgery group had improved 5-year PFS (P = 0.028). T-cell lymphoma, involvement of multiple gastrointestinal regions and extranodal involvement, higher scores for International Prognostic Index (IPI), more advanced Ann Arbor stage, lactate dehydrogenase (LDH) levels above 215 U/L, and management without combined therapy were prognostic for shorter PFS and OS in univariate analyses. Individuals who received R0 resection or gross resection had improved 5-year PFS and OS. Cox regression analysis demonstrated that primary T-cell lymphoma was an independent negative prognostic factor for both OS and PFS. CONCLUSION: Combined therapy is an independent prognostic factor for long-term survival in small intestinal lymphoma. Gross resection is recommended in patients with small intestinal lymphoma and leads to improved PFS without significantly increasing the risk of complications. Emergency surgery does not lead to poor prognosis. However, caution is warranted in the management of all patients, because of the high risk of post-operative complications and potential for early mortality.


Subject(s)
Digestive System Surgical Procedures/methods , Intestinal Neoplasms/surgery , Intestine, Small , Lymphoma, T-Cell/surgery , Adult , Aged , Aged, 80 and over , Disease-Free Survival , Female , Follow-Up Studies , Humans , Intestinal Neoplasms/diagnosis , Intestinal Neoplasms/mortality , Lymphoma, T-Cell/diagnosis , Lymphoma, T-Cell/mortality , Male , Middle Aged , Prognosis , Retrospective Studies , Survival Rate/trends , Taiwan/epidemiology , Time Factors , Young Adult
18.
J Clin Neurosci ; 26: 138-40, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26804925

ABSTRACT

Primary T-cell lymphomas of the central nervous system (CNS) are uncommon, but aggressive and increasing in incidence. We describe a rare case of T-cell lymphoma in a cerebellar location, to our knowledge the first reported case demonstrating gamma/delta receptor expression. Additionally, we elaborate on key diagnostic features and review all nine patients with primary CNS lymphoma of cytotoxic T-cell phenotype reported in the literature. A 26-year-old female medical student presented with a 6 week history of nausea, vomiting and dizziness. MRI revealed a 2 cm cerebellar mass. The tumor was subtotally resected, and pathologic examination of a subtotal resection specimen demonstrated peripheral T-cell lymphoma, not otherwise specified, with a gamma/delta cytotoxic T-cell phenotype. She subsequently started high dose methotrexate and cytarabine. We report a unique case of primary CNS gamma delta CD8+ T-cell lymphoma lineage in a young female patient. While these are rare entities, it is an important differential diagnosis to consider. Therapy should be tailored to the patient, and involves resection with adjuvant chemotherapy, radiotherapy or autologous stem-cell based treatments.


Subject(s)
Central Nervous System Neoplasms/diagnosis , Lymphoma, T-Cell/diagnosis , Receptors, Antigen, T-Cell, gamma-delta , T-Lymphocytes, Cytotoxic/pathology , Adult , Central Nervous System Neoplasms/surgery , Female , Humans , Lymphoma, T-Cell/surgery , Magnetic Resonance Imaging , T-Lymphocytes/pathology
19.
Gan To Kagaku Ryoho ; 43(12): 1620-1622, 2016 Nov.
Article in Japanese | MEDLINE | ID: mdl-28133077

ABSTRACT

The patient was 77-year-old man. He visited our hospital with the chief complaint of an abdominal mass in March 2015. We diagnosed the patient with transverse colon cancer and he was suspected of having malignant lymphoma. In March 2016, we attempted to perform right hemicolectomy for the transverse colon cancer, but it was difficult because swollen lymph nodes had formed a large mass with the surrounding tissue, including vessels of the mesentery. We could only complete the surgery after mesenteric lymph node biopsy. On the basis of the results of this biopsy, we diagnosed angioimmunoblastic Tcell lymphoma. At first, we administered THP-COP therapy for malignant lymphoma. However, after 3 courses of this therapy, the patient suddenly developed ileus due to the aforementioned colon cancer. According to enhanced CT performed at the onset of intestinal obstruction, chemotherapy dramatically reduced the size of the intraperitoneal lymph nodes. We therefore concluded that it was able to treat the colon cancer. We performed right hemicolectomy in June 2015. Angioimmunoblastic T-cell lymphoma comprises only 2-3% of all malignant lymphoma cases. We experienced a rare case of complications from angioimmunoblastic T-cell lymphoma and colorectal cancer.


Subject(s)
Colonic Neoplasms/pathology , Lymphoma, T-Cell , Aged , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Biopsy , Colonic Neoplasms/drug therapy , Colonic Neoplasms/surgery , Humans , Lymphoma, T-Cell/drug therapy , Lymphoma, T-Cell/surgery , Male , Neoadjuvant Therapy , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...